127 related articles for article (PubMed ID: 15361472)
1. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.
Saaristo A; Tammela T; Timonen J; Yla-Herttuala S; Tukiainen E; Asko-Seljavaara S; Alitalo K
FASEB J; 2004 Nov; 18(14):1707-9. PubMed ID: 15361472
[TBL] [Abstract][Full Text] [Related]
2. Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.
Honkonen KM; Visuri MT; Tervala TV; Halonen PJ; Koivisto M; Lähteenvuo MT; Alitalo KK; Ylä-Herttuala S; Saaristo AM
Ann Surg; 2013 May; 257(5):961-7. PubMed ID: 23013803
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K
FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis.
Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH
J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012
[TBL] [Abstract][Full Text] [Related]
5. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
7. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
8. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.
Goldman J; Le TX; Skobe M; Swartz MA
Circ Res; 2005 Jun; 96(11):1193-9. PubMed ID: 15890974
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication.
Gurunluoglu R; Meirer R; Shafighi M; Huemer GM; Yilmaz B; Piza-Katzer H
Microsurgery; 2005; 25(5):433-41. PubMed ID: 16032725
[TBL] [Abstract][Full Text] [Related]
11. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
12. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
13. Targeted treatment for lymphedema and lymphatic metastasis.
Tervala T; Suominen E; Saaristo A
Ann N Y Acad Sci; 2008; 1131():215-24. PubMed ID: 18519974
[TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis VEGF165 gene therapy with AdVEGF- a new delay procedure for flaps].
Holzbach T; Taskov C; Neshkova I; Holm PS; Konerding MA; Schams D; Gänsbacher B; Biemer E; Giunta RE
Handchir Mikrochir Plast Chir; 2005 Dec; 37(6):365-74. PubMed ID: 16388451
[TBL] [Abstract][Full Text] [Related]
15. Lymphangiogenesis in regenerating tissue: is VEGF-C sufficient?
Breier G
Circ Res; 2005 Jun; 96(11):1132-4. PubMed ID: 15947252
[No Abstract] [Full Text] [Related]
16. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
17. Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice.
Ikomi F; Kawai Y; Nakayama J; Ogiwara N; Sasaki K; Mizuno R; Ohhashi T
Microcirculation; 2008 Oct; 15(7):591-603. PubMed ID: 18951277
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats.
Meirer R; Huemer GM; Oehlbauer M; Wanner S; Piza-Katzer H; Kamelger FS
J Plast Reconstr Aesthet Surg; 2007; 60(3):266-71. PubMed ID: 17293284
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.
Ji RC; Miura M; Qu P; Kato S
Microsc Res Tech; 2004 Jun; 64(3):279-86. PubMed ID: 15452895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
